Topic · Rules
Regulators, laws, patents, tariffs and enforcement. 7 stories from 4 countries.
7 stories
XBAcross bordersRulesExplainer
The main semaglutide patent has lapsed in India, China and Brazil and Canada has approved a first generic, while China's copies wait on data protection to April 2027 and Novo leans on its Wegovy pill.
USUnited StatesRules
Treasury proposed on 22 October 2026 to add biotechnology, including biomanufacturing equipment and facilities, to US outbound investment screening under the COINS Act.
GBUnited KingdomRules
The MHRA and West Midlands Police seized more than 12,000 fake retatrutide and tirzepatide pens, valued at about £2 million, from a Birmingham industrial unit on October 14, 2026.
CNChinaRules
FDA added two Chinese GLP 1 ingredient makers to Import Alert 66-40, so all drugs from their sites can be detained at the US border.
CNChinaRules
Drug makers are told to plan for fewer Chinese contract suppliers on US-funded work.
USUnited StatesRules
A factory under construction became a way to avoid a tariff.
BEBelgiumRules
European-made peptide drugs got a ceiling on what they pay to enter the US.
